Adverse events50

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

41 to 50 of 50

Type	Event	Organ system	Group	Affected	At risk
serious	Anxiety	Psychiatric disorders	ALKS 3831	0	211
serious	Anxiety	Psychiatric disorders	Olanzapine	2	215
serious	Varicella	Infections and infestations	ALKS 3831	1	211
serious	Varicella	Infections and infestations	Olanzapine	0	215
serious	Limb deformity	Musculoskeletal and connective tissue disorders	ALKS 3831	1	211
serious	Limb deformity	Musculoskeletal and connective tissue disorders	Olanzapine	0	215
serious	Schizophrenia	Psychiatric disorders	ALKS 3831	3	211
serious	Schizophrenia	Psychiatric disorders	Olanzapine	2	215
serious	Bipolar I Disorder	Psychiatric disorders	ALKS 3831	0	211
serious	Bipolar I Disorder	Psychiatric disorders	Olanzapine	1	215

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
ClinicalTrials.govNo license stated
NIH RePORTER's clinical studies and project filesPublic domain

Each source's terms

ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
ClinicalTrials.govnone stated
NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT03187769/events?page=3